Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|August 12, 2024
Identification of potential inhibitors for drug-resistant EGFR mutations in non-small cell lung cancer using whole exome sequencing dataNagasundaram Nagarajan, Chittibabu Guda
Journal of Cellular Biochemistry|January 26, 2018
Exploring the functional impact of mutational drift in LRRK2 gene and identification of specific inhibitors for the treatment of Parkinson diseaseNagasundaram Nagarajan, Jaynthy Chellam, Rajaretinam Rajesh Kannan
Journal of Biomolecular Structure & Dynamics|June 24, 2022
PITRM1 interaction studies with amyloidogenic nonapeptide mutants of familial Alzheimer's diseaseCarlton Ranjith Wilson Alphonse, Rajaretinam Rajesh Kannan, Nagasundaram Nagarajan
Journal of Translational Medicine|June 19, 2026
Machine learning-driven QSAR modeling combined with single cell transcriptomics identifies novel drug targets for lung cancerNagasundaram Nagarajan, Sushil Kumar Shakyawar, Kayode Raheem, et al.
Heliyon|September 30, 2020
Molecular interaction of human acetylcholinesterase with trans-tephrostachin and derivatives for Alzheimer's diseaseArjun Pitchai, Rajesh Kannan Rajaretinam, Rajasekar Mani, et al.
Neuroscience Letters|October 6, 2018
Zebrafish bio-assay guided isolation of human acetylcholinesterase inhibitory trans-tephrostachin from Tephrosia purpurea (L.) PersArjun Pitchai, Nagasundaram Nagarajan, Samuel Gnana Prakash Vincent, et al.
Molecular Biology Reports|April 15, 2019
In silico screening of sugar alcohol compounds to inhibit viral matrix protein VP40 of Ebola virusNagasundaram Nagarajan, Edward K Y Yapp, Nguyen Quoc Khanh Le, et al.
Biomed Research International|December 31, 2019
Application of Computational Biology and Artificial Intelligence Technologies in Cancer Precision Drug DiscoveryNagasundaram Nagarajan, Edward K Y Yapp, Nguyen Quoc Khanh Le, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 10, 2026
Characterizing ghrelin's role in dysregulating GLP-1-mediated function and promoting the development of alcohol-associated liver diseaseSundararajan Mahalingam, Ramesh Bellamkonda, Kusum K Kharbanda, et al.
Pageof 1